Expertise in
3
conditions

Suzanne J. Hodgkinson

St. Vincent's Hospital, 
Darlinghurst, NSW, AU 
Expertise in
3
conditions
St. Vincent's Hospital, 
Darlinghurst, NSW, AU 

Overview

Suzanne Hodgkinson practices practicing medicine in Darlinghurst, Australia.

Ms. Hodgkinson is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, Thrombectomy, and Stent Placement.

She is actively involved in clinical research, co-authoring 114 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

St. Vincent's Hospital, Darlinghurst, NSW, Australia
Other Locations
Elizabeth St, 21, Liverpool, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1/2, Two-part, Open-label Dose-escalation and Double-blind, Placebo-controlled Dose-expansion Study With an Open-label Extension to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
A Phase 1/2, Two-part, Open-label Dose-escalation and Double-blind, Placebo-controlled Dose-expansion Study With an Open-label Extension to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
Enrollment Status: Terminated
Publish Date: February 23, 2024
Intervention Type: Drug, Biological
Study Drug: ATA188
Study Phase: Phase 1/Phase 2
A 2-year Prospective Study to Evaluate the Onset of Action of Mavenclad® in Subjects With Highly Active Relapsing Multiple Sclerosis (MAGNIFY)
A 2-year Prospective Study to Evaluate the Onset of Action of Mavenclad® in Subjects With Highly Active Relapsing Multiple Sclerosis (MAGNIFY)
Enrollment Status: Completed
Publish Date: March 16, 2023
Intervention Type: Drug
Study Drug: Mavenclad®
Study Phase: Phase 4
View 1 Less Clinical Trial

114 Total Publications

Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.
Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 04, 2026

Frequently Asked Questions about Suzanne J. Hodgkinson

Is Suzanne J. Hodgkinson a top-rated expert for Multiple Sclerosis (MS)?

MediFind is an objective health platform that identifies experts based on real-world data. Suzanne J. Hodgkinson is classified as an Elite expert for Multiple Sclerosis (MS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Suzanne J. Hodgkinson participate in research or clinical trials?

Yes. Suzanne J. Hodgkinson has published 114 articles and abstracts on conditions like Multiple Sclerosis (MS). You can view a list of Suzanne J. Hodgkinson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hodgkinson's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile